-
Starpharma & Eli Lilly Sign New Drug Delivery Collaboration for Human PharmaceuticalsStarpharma Holdings Limited recently announced the signing of a new agreement with Eli Lilly and Company under which Starpharma’s dendrimer drug delivery technology will be applied to enhance2010/2/21
-
Catalent Pharma Solutions Expands Capabilities in GermanyCatalent Pharma Solutions, a leading provider of outsourced dose form manufacturing and packaging to the global pharmaceutical industry, recently announced it has expanded its capabilities in2010/2/21
-
BASF to break ground for new sodium methylate plant in BrazilWorld-scale plant with a capacity of 60,000 metric tons Catalyst for production of biodiesel Start of operations scheduled for 2011 Ludwigshafen , Germany / Guaratinguetá, Brazil – February2010/2/11
-
UK Company to Begin First Stroke Stem Cell TrialThe UK Gene Therapy Advisory Committee (GTAC) has given the go-ahead to UK company ReNeuron to go ahead with the first-ever clinical trial to test its ReN001 stem cell therapy as a treatment for str2010/2/11
-
Novartis Moves for Potent Hepatitis C TreatmentNovartis has moved to seal an exclusive licence agreement with Swiss group Debiopharm for the development, manufacture and commercialisation of Debio 025 (alisporivir), which has shown a potent effe2010/2/11
-
New brilliance in coatings design: Paliocrom®Brilliant Orange from BASFNew generation of effect pigments Ultra-high chroma and excellent hiding power Paliocrom® Brilliant Orange L 2850 is the first of a new generation of effect pigments from BASF. Exceptional2010/2/10
-
Frost & Sullivan's report on rheumatoid arthritis therapeutics market in ThailandResearch and Markets (http://www.researchandmarkets.com/research/1c756d/rheumatoid_arthrit) has announced the addition of Frost & Sullivan's new report "Rheumatoid Arthritis Therapeutics Market in2010/2/10
-
Survey reveals need for better access to levalbuterol for asthma patientsA recent electronic survey of US asthma experts demonstrated the need for better access to levalbuterol, the fast-acting medicine used to treat the narrowing of airways (bronchospasm) caused by asthma2010/2/10
-
Actavis To Expand Iceland FacilityActavis has said that it will be expanding its manufacturing site in Iceland, whereby increasing capacity at the site by 50%. With this decision, the company also intends to create 50 new jobs. The c2010/2/9
-
GSK Forms New Specialized R&D UnitGSK has established a new standalone unit specialising in the development and commercialisation of medicines for rare diseases. Marc Dunoyer, president of Asia Pacific and chairman of Japan at GSK, is2010/2/9